PL3597038T3 - Humanizowane gryzonie wykazujące ekspresję łańcuchów ciężkich zawierających domeny vl - Google Patents

Humanizowane gryzonie wykazujące ekspresję łańcuchów ciężkich zawierających domeny vl

Info

Publication number
PL3597038T3
PL3597038T3 PL19191081T PL19191081T PL3597038T3 PL 3597038 T3 PL3597038 T3 PL 3597038T3 PL 19191081 T PL19191081 T PL 19191081T PL 19191081 T PL19191081 T PL 19191081T PL 3597038 T3 PL3597038 T3 PL 3597038T3
Authority
PL
Poland
Prior art keywords
domains
heavy chains
chains containing
express heavy
humanized rodents
Prior art date
Application number
PL19191081T
Other languages
English (en)
Inventor
Lynn Macdonald
Cagan Gurer
Karolina A Meagher
Sean Stevens
Andrew J Murphy
Original Assignee
Regeneron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharmaceuticals, Inc. filed Critical Regeneron Pharmaceuticals, Inc.
Publication of PL3597038T3 publication Critical patent/PL3597038T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/462—Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/53—Hinge
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2318/00—Antibody mimetics or scaffolds
    • C07K2318/10—Immunoglobulin or domain(s) thereof as scaffolds for inserted non-Ig peptide sequences, e.g. for vaccination purposes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/20—Pseudochromosomes, minichrosomosomes
    • C12N2800/204—Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24046—Adamalysin (3.4.24.46)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Housing For Livestock And Birds (AREA)
  • Central Heating Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL19191081T 2012-02-01 2013-02-01 Humanizowane gryzonie wykazujące ekspresję łańcuchów ciężkich zawierających domeny vl PL3597038T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261593463P 2012-02-01 2012-02-01
US201261677538P 2012-07-31 2012-07-31
EP13704329.5A EP2809150B1 (en) 2012-02-01 2013-02-01 Humanized mice that express heavy chains containing vl domains
PCT/US2013/024295 WO2013116609A1 (en) 2012-02-01 2013-02-01 Humanized rodents that express heavy chains containing vl domains
EP19191081.9A EP3597038B1 (en) 2012-02-01 2013-02-01 Humanized rodents that express heavy chains containing vl domains

Publications (1)

Publication Number Publication Date
PL3597038T3 true PL3597038T3 (pl) 2021-11-08

Family

ID=47714588

Family Applications (2)

Application Number Title Priority Date Filing Date
PL19191081T PL3597038T3 (pl) 2012-02-01 2013-02-01 Humanizowane gryzonie wykazujące ekspresję łańcuchów ciężkich zawierających domeny vl
PL13704329T PL2809150T3 (pl) 2012-02-01 2013-02-01 Humanizowane myszy wykazujące ekspresję łańcuchów ciężkich zawierających domeny VL

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL13704329T PL2809150T3 (pl) 2012-02-01 2013-02-01 Humanizowane myszy wykazujące ekspresję łańcuchów ciężkich zawierających domeny VL

Country Status (26)

Country Link
US (3) US20130212719A1 (pl)
EP (3) EP3912465A1 (pl)
JP (6) JP2015505477A (pl)
KR (2) KR20140123983A (pl)
CN (2) CN106117364B (pl)
AU (3) AU2013204758B2 (pl)
BR (1) BR112014018843B1 (pl)
CA (1) CA2863175A1 (pl)
CY (2) CY1122419T1 (pl)
DK (2) DK2809150T3 (pl)
ES (2) ES2870703T3 (pl)
HR (2) HRP20192218T1 (pl)
HU (2) HUE055610T2 (pl)
IL (3) IL233827A0 (pl)
LT (2) LT3597038T (pl)
ME (1) ME03611B (pl)
MX (2) MX373286B (pl)
NZ (5) NZ719228A (pl)
PL (2) PL3597038T3 (pl)
PT (2) PT3597038T (pl)
RS (2) RS62023B1 (pl)
RU (2) RU2770016C2 (pl)
SG (3) SG10201913428QA (pl)
SI (2) SI2809150T1 (pl)
SM (2) SMT202100401T1 (pl)
WO (1) WO2013116609A1 (pl)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2436044T3 (es) * 2008-05-23 2013-12-26 Ablexis, Llc Procedimiento de generación de anticuerpos de dominio VL individual en animales transgénicos
US9445581B2 (en) 2012-03-28 2016-09-20 Kymab Limited Animal models and therapeutic molecules
EP2604110B1 (en) 2009-07-08 2016-11-30 Kymab Limited Animal models and therapeutic molecules
MY172618A (en) * 2010-08-02 2019-12-06 Regeneron Pharma Mice that make binding proteins comprising vl domains
SMT202100357T1 (it) 2011-08-05 2021-07-12 Regeneron Pharma Topi di catena leggera universale umanizzata
JP5813880B2 (ja) 2011-09-19 2015-11-17 カイマブ・リミテッド ヒトへの使用に合わせて作製された抗体、可変ドメインおよび鎖
EP2761008A1 (en) 2011-09-26 2014-08-06 Kymab Limited Chimaeric surrogate light chains (slc) comprising human vpreb
US9253965B2 (en) 2012-03-28 2016-02-09 Kymab Limited Animal models and therapeutic molecules
GB201122047D0 (en) * 2011-12-21 2012-02-01 Kymab Ltd Transgenic animals
KR101924805B1 (ko) 2011-12-20 2018-12-04 리제너론 파마슈티칼스 인코포레이티드 인간화 경쇄 마우스
PL3597038T3 (pl) * 2012-02-01 2021-11-08 Regeneron Pharmaceuticals, Inc. Humanizowane gryzonie wykazujące ekspresję łańcuchów ciężkich zawierających domeny vl
US10251377B2 (en) 2012-03-28 2019-04-09 Kymab Limited Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
GB2502127A (en) 2012-05-17 2013-11-20 Kymab Ltd Multivalent antibodies and in vivo methods for their production
MX379274B (es) 2012-06-12 2025-03-10 Regeneron Pharma Animales no humanos humanizados con loci de cadena pesada de inmunoglobulina restringidos.
KR20160025033A (ko) 2013-02-20 2016-03-07 리제너론 파마슈티칼스 인코포레이티드 변형된 면역글로불린 중쇄 서열을 갖는 비인간 동물
US9788534B2 (en) 2013-03-18 2017-10-17 Kymab Limited Animal models and therapeutic molecules
US9783618B2 (en) 2013-05-01 2017-10-10 Kymab Limited Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
US11707056B2 (en) 2013-05-02 2023-07-25 Kymab Limited Animals, repertoires and methods
US9783593B2 (en) 2013-05-02 2017-10-10 Kymab Limited Antibodies, variable domains and chains tailored for human use
WO2015049517A2 (en) 2013-10-01 2015-04-09 Kymab Limited Animal models and therapeutic molecules
SG11201607015VA (en) 2014-03-21 2016-09-29 Regeneron Pharma V<sb>L</sb> ANTIGEN BINDING PROTEINS EXHIBITING DISTINCT BINDING CHARACTERISTICS
EP3895528A1 (en) 2014-03-21 2021-10-20 Regeneron Pharmaceuticals, Inc. Non-human animals that make single domain binding proteins
AU2016232715A1 (en) * 2015-03-19 2017-09-28 Regeneron Pharmaceuticals, Inc. Non-human animals that select for light chain variable regions that bind antigen
CA2981077A1 (en) * 2015-04-03 2016-10-06 Dana-Farber Cancer Institute, Inc. Composition and methods of genome editing of b-cells
CN109072191B (zh) * 2016-04-04 2024-03-22 苏黎世联邦理工学院 用于蛋白生产和文库产生的哺乳动物细胞系
CA3022997C (en) 2016-05-20 2023-07-18 Regeneron Pharmaceuticals, Inc. Methods for breaking immunological tolerance using multiple guide rnas
US11089767B2 (en) * 2017-03-30 2021-08-17 Utah State University Transgenic silkworms expressing spider silk
KR20250022220A (ko) * 2017-12-05 2025-02-14 리제너론 파마슈티칼스 인코포레이티드 조작된 면역글로불린 람다 경쇄를 갖는 비-인간 동물 및 그의 용도
TWI842701B (zh) * 2018-03-24 2024-05-21 美商再生元醫藥公司 用於產生抗肽-mhc複合物之治療性抗體的經基因修飾的非人類動物、其製法與用途
IL318469A (en) * 2018-06-14 2025-03-01 Regeneron Pharma Non-human animals capable of reorganizing transgenic DH-DH, and their uses
EP4211155A1 (en) 2020-09-11 2023-07-19 Regeneron Pharmaceuticals, Inc. Identification and production of antigen-specific antibodies
IL303626A (en) 2020-12-16 2023-08-01 Regeneron Pharma Mice expressing humanized fc alpha receptors
CN114645042A (zh) * 2020-12-18 2022-06-21 中国食品药品检定研究院 一种构建具有表达荧光素酶和红色荧光蛋白的重组巨噬细胞的转基因小鼠的方法
CN114196626A (zh) * 2022-02-16 2022-03-18 北京国卫生物科技有限公司 脐带间充质干细胞及其分离培养扩增方法
CN118339300A (zh) * 2024-01-02 2024-07-12 江苏集萃药康生物科技股份有限公司 产生人源化抗体的动物模型及其构建方法
WO2026030428A2 (en) 2024-08-01 2026-02-05 Regeneron Pharmaceuticals, Inc. Prostate-specific antigen peptides and uses thereof
WO2026035843A2 (en) 2024-08-06 2026-02-12 Regeneron Pharmaceuticals, Inc. Non-human animals having modified immunoglobulin heavy chain constant region locus and uses thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774279B2 (en) 1997-05-30 2004-08-10 Carnegie Institution Of Washington Use of FLP recombinase in mice
MXPA03001915A (es) * 2000-08-03 2004-09-10 Therapeutic Human Polyclonals Produccion de anticuerpos humanizados en animales transgenicos.
US6596541B2 (en) * 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
CN101016543A (zh) * 2000-11-17 2007-08-15 罗切斯特大学 筛选编码抗原特异性免疫球蛋白分子或其抗原特异性片段的多核苷酸的方法
US7473557B2 (en) 2001-06-06 2009-01-06 Regeneron Pharmaceuticals, Inc. Method for targeting transcriptionally active loci
AU2002357410A1 (en) * 2001-12-21 2003-07-09 Thromb-X Nv Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells
WO2003081993A2 (en) * 2002-03-22 2003-10-09 Origen Therapeutics Transgenic aves producing human polyclonal antibodies
WO2005007696A2 (en) * 2003-07-15 2005-01-27 Therapeutic Human Polyclonals, Inc. Humanized immunoglobulin loci
ES2463476T3 (es) 2004-10-19 2014-05-28 Regeneron Pharmaceuticals, Inc. Método para generar un ratón homocigótico para una modificación genética
CA2584814A1 (en) * 2004-10-22 2006-05-04 Therapeutic Human Polyclonals, Inc. Suppression of endogenous immunoglobulin expression in non-human transgenic animals
JP5514539B2 (ja) * 2006-03-31 2014-06-04 メダレックス・リミテッド・ライアビリティ・カンパニー ヒト抗体の調製に用いるためのキメラ抗体を発現するトランスジェニック動物
EP2064325B1 (en) * 2006-09-01 2011-12-07 Therapeutic Human Polyclonals, Inc. Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals
EP2195346B1 (en) * 2007-08-30 2018-01-03 The Walter and Eliza Hall Institute of Medical Research Dendritic cell marker and uses thereof
WO2009041613A1 (ja) * 2007-09-26 2009-04-02 Chugai Seiyaku Kabushiki Kaisha 抗体定常領域改変体
US7659842B2 (en) 2007-10-24 2010-02-09 Infineon Technologies Ag Quantization error reduction in PWM full-MASH converters
ES2436044T3 (es) * 2008-05-23 2013-12-26 Ablexis, Llc Procedimiento de generación de anticuerpos de dominio VL individual en animales transgénicos
KR20110029156A (ko) * 2008-06-27 2011-03-22 메뤼스 베.페. 항체 생산 비-인간 포유동물
RU2011111725A (ru) * 2008-08-29 2012-10-10 Симфоген А/С (Dk) Способ клонирования антител птиц
US9085795B2 (en) * 2009-02-04 2015-07-21 Molecular Innovations, Inc. Methods for screening candidate agents for modulating prorenin and renin, assays for detecting prorenin and antibodies
EP2604110B1 (en) * 2009-07-08 2016-11-30 Kymab Limited Animal models and therapeutic molecules
WO2011158009A1 (en) * 2010-06-17 2011-12-22 Kymab Limited Animal models and therapeutic molecules
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
MY172618A (en) * 2010-08-02 2019-12-06 Regeneron Pharma Mice that make binding proteins comprising vl domains
DK4067496T5 (da) * 2011-02-25 2024-07-22 Regeneron Pharma ADAM6-mus
SMT202100357T1 (it) * 2011-08-05 2021-07-12 Regeneron Pharma Topi di catena leggera universale umanizzata
KR101924805B1 (ko) * 2011-12-20 2018-12-04 리제너론 파마슈티칼스 인코포레이티드 인간화 경쇄 마우스
PL3597038T3 (pl) * 2012-02-01 2021-11-08 Regeneron Pharmaceuticals, Inc. Humanizowane gryzonie wykazujące ekspresję łańcuchów ciężkich zawierających domeny vl
MX379274B (es) * 2012-06-12 2025-03-10 Regeneron Pharma Animales no humanos humanizados con loci de cadena pesada de inmunoglobulina restringidos.
RS66884B1 (sr) * 2016-11-04 2025-07-31 Regeneron Pharma Ne-humane životinje koje imaju konstruisani lokus imunoglobulinskog lambda lakog lanca

Also Published As

Publication number Publication date
LT2809150T (lt) 2019-10-25
SG10201606256TA (en) 2016-09-29
JP2023168590A (ja) 2023-11-24
SMT202100401T1 (it) 2021-09-14
IL268675A (en) 2019-10-31
EP3597038A1 (en) 2020-01-22
SG10201913428QA (en) 2020-03-30
CN104202971A (zh) 2014-12-10
EP2809150B1 (en) 2019-09-18
IL233827A0 (en) 2014-09-30
MX373286B (es) 2020-05-20
IL261280A (en) 2018-10-31
WO2013116609A1 (en) 2013-08-08
AU2017251848B2 (en) 2020-02-20
BR112014018843A8 (pt) 2019-01-29
JP7525579B2 (ja) 2024-07-30
NZ627977A (en) 2016-06-24
NZ719228A (en) 2022-08-26
MX2020003491A (es) 2022-10-25
BR112014018843A2 (pt) 2017-07-04
CY1122419T1 (el) 2021-01-27
DK3597038T3 (da) 2021-06-28
EP3597038B1 (en) 2021-04-21
CA2863175A1 (en) 2013-08-08
HRP20210987T1 (hr) 2021-09-17
JP2015505477A (ja) 2015-02-23
BR112014018843B1 (pt) 2024-02-20
EP3912465A1 (en) 2021-11-24
KR20140123983A (ko) 2014-10-23
NZ793447A (en) 2024-05-31
JP2023014242A (ja) 2023-01-26
CN106117364B (zh) 2021-08-31
KR20190006029A (ko) 2019-01-16
RS62023B1 (sr) 2021-07-30
AU2015246154A1 (en) 2015-11-12
JP2018075041A (ja) 2018-05-17
AU2017251848A1 (en) 2017-11-16
SI2809150T1 (sl) 2019-11-29
HUE046744T2 (hu) 2020-03-30
SMT201900685T1 (it) 2020-01-14
SI3597038T1 (sl) 2021-07-30
JP6942757B2 (ja) 2021-09-29
IL268675B (en) 2020-11-30
MX2019002517A (es) 2019-06-17
RU2018122695A3 (pl) 2021-10-06
CY1124361T1 (el) 2022-07-22
EP2809150A1 (en) 2014-12-10
NZ810648A (en) 2025-11-28
US20170094955A1 (en) 2017-04-06
ES2753774T3 (es) 2020-04-14
RU2770016C2 (ru) 2022-04-14
RU2664185C2 (ru) 2018-08-15
PL2809150T3 (pl) 2020-04-30
JP2019170395A (ja) 2019-10-10
RS59699B1 (sr) 2020-01-31
RU2018122695A (ru) 2019-03-06
ES2870703T3 (es) 2021-10-27
AU2013204758A1 (en) 2013-08-15
IL261280B (en) 2019-08-29
PT3597038T (pt) 2021-05-10
LT3597038T (lt) 2021-05-25
ME03611B (me) 2020-07-20
AU2015246154B2 (en) 2017-11-23
SG11201404477YA (en) 2014-08-28
HK1202771A1 (en) 2015-10-09
DK2809150T3 (da) 2019-12-09
US20130212719A1 (en) 2013-08-15
CN106117364A (zh) 2016-11-16
JP7187615B2 (ja) 2022-12-12
HRP20192218T1 (hr) 2020-03-06
NZ734504A (en) 2022-10-28
JP6698718B2 (ja) 2020-05-27
JP2021137030A (ja) 2021-09-16
PT2809150T (pt) 2019-12-09
RU2014133653A (ru) 2016-03-20
AU2013204758B2 (en) 2015-07-23
HUE055610T2 (hu) 2021-12-28
CN104202971B (zh) 2016-07-06
US20210368751A1 (en) 2021-12-02

Similar Documents

Publication Publication Date Title
IL268675B (en) Humanized rodents expressing heavy chains comprising vl complexes
IL268674A (en) Rodents with humanized IL-7
ZA201407272B (en) Anti-baff-anti-il-17 bispecific antibodies
PT3058134T (pt) Polímeros extracelulares de lama granular como agentes de colagem
GB2511165B (en) Multi-sash closure system
SI2746185T1 (sl) Zaporni šarnir
ZA201306526B (en) Roll-open closure
AU342768S (en) Latch for lunchbox
GB201321568D0 (en) Chain stopper
ZA201301102B (en) Closure arrangement
AU346180S (en) Spout
GB201214914D0 (en) Eye cab